Safety of Ocrelizumab in Multiple Sclerosis: Updated Analysis in Patients with Relapsing and Primary Progressive Multiple Sclerosis

Raed Alroughani, Stephen L. Hauser, Ludwig Kappos, Xavier Montalban, Licínio Craveiro, Richard Hughes, John Mcnamara, Ashish Pradhan, David Wormser, Harold Koendgen